And potentially we have a deal. What about the irish border . At one point it was that a twomonth high, 5 10 of a percent. And we are talking about 58 basis points, modestly steeper by a basis points as you had supplied coming from the front end earlier this week. Bitcoin, 10,000. Jonathan about the happen again. Alix 11,000 call . David it just keeps going. Extraordinary. We want to get some news outside of the business world. First word news. Emma good morning. Breaking news, matt lauer we understand has been fired, according to the new york times. More on that story as it crosses. On capitol hill, republican plans to push a tax bill through by the end of the year picking up steam. There was a closeddoor session, called somewhat of a lovefest. The Budget Committee looking to send the tax bill for a vote as early as tomorrow. And north korea warns that the latest missile can deliver a Nuclear Warhead anywhere on the u. S. Mainland. The regime conducted its first missile test in two mo
KKR acquired Healthium Medtech Ltd., a leading Indian medical devices company, from Apax Partners. The deal, valued at approximately Rs 7000 crore, involves a special purpose vehicle owned by KKR-managed funds gaining control of Healthium. Healthium, the fourth-largest surgical suture manufacturer globally, maintains a strong presence in India and abroad, with KKR aiming to leverage its expertise to further expand its reach
KKR and Apax have signed a binding agreement for purchase of the Bengaluru-based company, with a formal announcement expected as early as Monday, the people cited said. Moneycontrol was first to report on Saturday that KKR was the highest bidder for Healthium. Mankind-ChrysCapital had offered ₹6,500 crore ($780 million), said the people cited.
KKR to acquire Healthium Medtech for Rs 7000 crore from Apax Partners. Novo Holdings, Mankind Pharma, and ChrysCapital competed in the bidding. Anish Bafna will continue to lead Healthium under KKR ownership.
Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the.